Literature DB >> 23043871

Association between Anaplasma phagocytophilum seroprevalence in dogs and distribution of Ixodes ricinus and Ixodes persulcatus ticks in Latvia.

Inese Berzina1, Valentina Capligina, Antra Bormane, Agne Pavulina, Viesturs Baumanis, Renate Ranka, Rita Granta, Ilze Matise.   

Abstract

Anaplasma phagocytophilum has been detected in ticks in Latvia; however, this is the first study to investigate this pathogen in dogs in Latvia. The aims of this study were: (i) to determine A. phagocytophilum seroprevalence in dogs, (ii) to correlate A. phagocytophilum seroprevalence in dogs with the geographic distribution of the tick species Ixodes ricinus and Ixodes persulcatus, and (iii) to determine if seroprevalence for A. phagocytophilum is higher in dogs with clinical signs suggestive of canine granulocytic anaplasmosis (CGA). Peripheral venous blood samples were collected from 3 dog groups: (i) clinically healthy dogs (HD, n=400), (ii) clinically healthy hunting dogs (HHD, n=41), and (iii) dogs with a clinical suspicion of anaplasmosis (SD, n=29). Sampling was carried out in regions inhabited by I. ricinus (IR), I. persulcatus (IP), and in regions where both tick species were present (M). SNAP 4Dx test (IDEXX) was used to detect antibodies against A. phagocytophilum in the blood of all dogs; nested PCR was performed in selected dogs of the SD group. Seroprevalence for A. phagocytophilum was calculated and correlated with the prevalent tick species in the region. A. phagocytophilum seroprevalence was 11.0% in HD, 12% in HHD, and 17% in SD with no significant differences among groups. In the IR region, seroprevalence was 12.5% (34/272) while seroprevalence in the M region was 17% (13/76), and both were significantly higher than the seroprevalence of 2% in the IP region (2/93; p<0.0005). One CGA case was diagnosed. We conclude that A. phagocytophilum seroprevalence in Latvia is within the range reported from other European countries. CGA should be included in the differential list in Latvian dogs with appropriate clinical signs and laboratory abnormalities, especially in I. ricinus habitat areas.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23043871     DOI: 10.1016/j.ttbdis.2012.08.003

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  6 in total

1.  Development of a real-time PCR method for rapid diagnosis of canine babesiosis and anaplasmosis.

Authors:  Agnija Kivrane; Agne Namina; Maija Seleznova; Sarmite Akopjana; Valentina Capligina; Renate Ranka
Journal:  Parasit Vectors       Date:  2021-05-20       Impact factor: 3.876

2.  Tick-borne pathogens in ticks collected from dogs, Latvia, 2011-2016.

Authors:  Agne Namina; Valentina Capligina; Maija Seleznova; Rudolfs Krumins; Darja Aleinikova; Agnija Kivrane; Sarmite Akopjana; Marija Lazovska; Inese Berzina; Renate Ranka
Journal:  BMC Vet Res       Date:  2019-11-06       Impact factor: 2.741

Review 3.  Zoonotic Tick-Borne Pathogens in Temperate and Cold Regions of Europe-A Review on the Prevalence in Domestic Animals.

Authors:  Andrea Springer; Antje Glass; Anna-Katharina Topp; Christina Strube
Journal:  Front Vet Sci       Date:  2020-12-10

Review 4.  Epidemiological and Clinicopathological Features of Anaplasma phagocytophilum Infection in Dogs: A Systematic Review.

Authors:  Sarah El Hamiani Khatat; Sylvie Daminet; Luc Duchateau; Latifa Elhachimi; Malika Kachani; Hamid Sahibi
Journal:  Front Vet Sci       Date:  2021-06-23

5.  Seroprevalence against Borrelia burgdorferi sensu lato and occurence of antibody co-expression with Anaplasma phagocytophilum in dogs in Latvia.

Authors:  Inese Berzina; Ilze Matise
Journal:  Ir Vet J       Date:  2013-05-21       Impact factor: 2.146

6.  Haemotropic Mycoplasma species in pet cats in Latvia: a study, phylogenetic analysis and clinical case report.

Authors:  Inese Berzina; Valentina Capligina; Agne Namina; Alina Visocka; Renate Ranka
Journal:  JFMS Open Rep       Date:  2021-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.